• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素百年:庆祝糖尿病治疗的过去、现在和未来。

100 years of insulin: celebrating the past, present and future of diabetes therapy.

机构信息

Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.

The Center for Diabetes & Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Nat Med. 2021 Jul;27(7):1154-1164. doi: 10.1038/s41591-021-01418-2. Epub 2021 Jul 15.

DOI:10.1038/s41591-021-01418-2
PMID:34267380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8802620/
Abstract

The year 2021 marks the centennial of Banting and Best's landmark description of the discovery of insulin. This discovery and insulin's rapid clinical deployment effectively transformed type 1 diabetes from a fatal diagnosis into a medically manageable chronic condition. In this Review, we describe key accomplishments leading to and building on this momentous occasion in medical history, including advancements in our understanding of the role of insulin in diabetes pathophysiology, the molecular characterization of insulin and the clinical use of insulin. Achievements are also viewed through the lens of patients impacted by insulin therapy and the evolution of insulin pharmacokinetics and delivery over the past 100 years. Finally, we reflect on the future of insulin therapy and diabetes treatment, as well as challenges to be addressed moving forward, so that the full potential of this transformative discovery may be realized.

摘要

2021 年是班廷和贝斯特划时代地描述胰岛素发现一百周年。这一发现和胰岛素的迅速临床应用,将 1 型糖尿病从致命的诊断转变为可通过医学手段控制的慢性疾病。在这篇综述中,我们描述了促成这一医学史上重要时刻的关键成就,包括对胰岛素在糖尿病病理生理学中的作用的理解、胰岛素的分子特征以及胰岛素的临床应用方面的进展。我们还从接受胰岛素治疗的患者的角度以及过去 100 年来胰岛素药代动力学和给药方式的演变来看待这些成就。最后,我们反思了胰岛素治疗和糖尿病治疗的未来,以及未来需要解决的挑战,以便充分发挥这一变革性发现的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd53/8802620/af2735b9ccaf/nihms-1771018-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd53/8802620/49be43fb3542/nihms-1771018-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd53/8802620/33db8f0d8fab/nihms-1771018-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd53/8802620/1990a409c419/nihms-1771018-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd53/8802620/af2735b9ccaf/nihms-1771018-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd53/8802620/49be43fb3542/nihms-1771018-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd53/8802620/33db8f0d8fab/nihms-1771018-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd53/8802620/1990a409c419/nihms-1771018-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd53/8802620/af2735b9ccaf/nihms-1771018-f0004.jpg

相似文献

1
100 years of insulin: celebrating the past, present and future of diabetes therapy.胰岛素百年:庆祝糖尿病治疗的过去、现在和未来。
Nat Med. 2021 Jul;27(7):1154-1164. doi: 10.1038/s41591-021-01418-2. Epub 2021 Jul 15.
2
CELEBRATING 100 YEARS OF INSULIN USE.庆祝胰岛素使用 100 周年。
Acta Clin Croat. 2022 Nov;61(3):482-487. doi: 10.20471/acc.2022.61.03.13.
3
Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.1型和2型糖尿病的病理生理学:90年回顾
Postgrad Med J. 2016 Feb;92(1084):63-9. doi: 10.1136/postgradmedj-2015-133281. Epub 2015 Nov 30.
4
Modern insulin therapy for type 1 diabetes mellitus.1型糖尿病的现代胰岛素治疗
Prim Care. 1999 Dec;26(4):917-29. doi: 10.1016/s0095-4543(05)70139-1.
5
[Type I diabetes mellitus: insulin treatment].[1型糖尿病:胰岛素治疗]
Schweiz Med Wochenschr Suppl. 1994;60:7-13.
6
Insulin's sidekicks. Developing alternative medications for type 1 diabetes.胰岛素的辅助药物。开发1型糖尿病的替代药物。
Diabetes Forecast. 2013 Sep;66(9):38-40.
7
Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus.甘精胰岛素及其在1型和2型糖尿病治疗中的地位。
Expert Opin Pharmacother. 2006 Jul;7(10):1357-71. doi: 10.1517/14656566.7.10.1357.
8
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievement.多伦多发现胰岛素:开启百年科研与临床成就之旅。
Diabetologia. 2021 May;64(5):947-953. doi: 10.1007/s00125-020-05371-6. Epub 2021 Jan 25.
9
Insulin therapy in insulin-dependent (type I) diabetes mellitus.胰岛素依赖型(I型)糖尿病的胰岛素治疗。
Endocrinol Metab Clin North Am. 1992 Jun;21(2):281-312.
10
Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.糖尿病胰岛素给药与血糖监测方法:一项比较有效性综述的总结
J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. doi: 10.18553/jmcp.2012.18.s6-A.1.

引用本文的文献

1
PeptideMiner-neuropeptide discovery across the animal kingdom.PeptideMiner——跨动物界的神经肽发现
Gigascience. 2025 Jan 6;14. doi: 10.1093/gigascience/giaf078.
2
A Historical and Epistemological Review of Type 1 Diabetes Mellitus.1型糖尿病的历史与认识论回顾
J Clin Med. 2025 Jul 11;14(14):4923. doi: 10.3390/jcm14144923.
3
Peptide Drug: Design and Clinical Applications.肽类药物:设计与临床应用

本文引用的文献

1
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.特普利珠单抗改善并稳定了抗体阳性的高危个体的胰岛β细胞功能。
Sci Transl Med. 2021 Mar 3;13(583). doi: 10.1126/scitranslmed.abc8980.
2
Once-Weekly Semaglutide in Adults with Overweight or Obesity.每周一次司美格鲁肽在超重或肥胖成人中的应用。
N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10.
3
A global perspective on the issue of access to insulin.从全球视角看胰岛素获取问题。
MedComm (2020). 2025 Jul 25;6(8):e70287. doi: 10.1002/mco2.70287. eCollection 2025 Aug.
4
Strategic applications of methylene thioacetal bonds as disulfide surrogates in peptide drug discovery.亚甲基硫代缩醛键作为二硫键替代物在肽类药物发现中的战略应用。
Front Chem. 2025 Jun 27;13:1637329. doi: 10.3389/fchem.2025.1637329. eCollection 2025.
5
Assessment of diabetes knowledge, hypoglycaemia awareness, and adherence to insulin pen usage practices among diabetic patients: a cross-sectional study of determinants and educational needs.糖尿病患者的糖尿病知识、低血糖认知及胰岛素笔使用依从性评估:一项关于决定因素和教育需求的横断面研究
BMC Public Health. 2025 Jul 3;25(1):2305. doi: 10.1186/s12889-025-23566-7.
6
SIRT1 Regulates Iron Metabolism to Attenuate β-Cell Dedifferentiation by Inhibiting FoxO1 Acetylation.SIRT1通过抑制FoxO1乙酰化来调节铁代谢,从而减轻β细胞去分化。
Biol Trace Elem Res. 2025 Jun 13. doi: 10.1007/s12011-025-04689-9.
7
Real-world comparative outcomes of GLP-1 RA and semaglutide prescription among individuals with type 2 diabetes.2型糖尿病患者中GLP-1受体激动剂和司美格鲁肽处方的真实世界比较结果
medRxiv. 2025 Jun 4:2025.06.03.25328908. doi: 10.1101/2025.06.03.25328908.
8
Nanozyme-driven multifunctional dressings: moving beyond enzyme-like catalysis in chronic wound treatment.纳米酶驱动的多功能敷料:在慢性伤口治疗中超越类酶催化作用。
Mil Med Res. 2025 May 31;12(1):27. doi: 10.1186/s40779-025-00611-5.
9
Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration.生物大分子药物的脑递送策略:鼻内给药
Int J Nanomedicine. 2025 May 22;20:6463-6487. doi: 10.2147/IJN.S520768. eCollection 2025.
10
Tryptophan-Derived Metabolites and Glutamate Dynamics in Fatal Insulin Poisoning: Mendelian Randomization of Human Cohorts and Experimental Validation in Rat Models.色氨酸衍生代谢物与致命性胰岛素中毒中的谷氨酸动态变化:人类队列的孟德尔随机化研究及大鼠模型的实验验证
Int J Mol Sci. 2025 Apr 27;26(9):4152. doi: 10.3390/ijms26094152.
Diabetologia. 2021 May;64(5):954-962. doi: 10.1007/s00125-020-05375-2. Epub 2021 Jan 23.
4
Evolution of insulin at the edge of foldability and its medical implications.胰岛素在可折叠性边缘的演变及其医学意义。
Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29618-29628. doi: 10.1073/pnas.2010908117. Epub 2020 Nov 5.
5
Healthcare resource utilization and cost among patients with type 1 diabetes in the United States.美国 1 型糖尿病患者的医疗资源利用和成本。
J Manag Care Spec Pharm. 2020 Nov;26(11):1399-1410. doi: 10.18553/jmcp.2020.26.11.1399.
6
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus.二肽基肽酶 4 抑制剂在 2 型糖尿病治疗中的应用。
Nat Rev Endocrinol. 2020 Nov;16(11):642-653. doi: 10.1038/s41574-020-0399-8. Epub 2020 Sep 14.
7
A combined risk score enhances prediction of type 1 diabetes among susceptible children.联合风险评分增强了对易感儿童 1 型糖尿病的预测。
Nat Med. 2020 Aug;26(8):1247-1255. doi: 10.1038/s41591-020-0930-4. Epub 2020 Aug 7.
8
Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas.胰岛素给药装置的演变:从注射器、笔式注射器和泵到自制人工胰腺。
Diabetes Ther. 2020 Jun;11(6):1251-1269. doi: 10.1007/s13300-020-00831-z. Epub 2020 May 14.
9
The Evolution of Insulin and How it Informs Therapy and Treatment Choices.胰岛素的发展历程及其对治疗选择的启示。
Endocr Rev. 2020 Oct 1;41(5):733-55. doi: 10.1210/endrev/bnaa015.
10
The Do-It-Yourself Artificial Pancreas: A Comprehensive Review.自制人工胰腺:全面综述
Diabetes Ther. 2020 Jun;11(6):1217-1235. doi: 10.1007/s13300-020-00823-z. Epub 2020 Apr 30.